Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Bone and Joint Health Markers in Persons with Hemophilia A (PwHA) Treated with Emicizumab in HAVEN 3

Anna Kiialainen, PhD, Markus Niggli, PhD, Christine L. Kempton, MD MSc, Giancarlo Castaman, MD, Tiffany Y. Chang, MD MAS, Ido Paz-Priel, MD, Joanne I Adamkewicz, PhD, Gallia G. Levy, MD PhD

Blood (2019) 134 (Supplement_1): 626.

https://doi.org/10.1182/blood-2019-123689

Published: 2019

Journal Articles

All-Cause and Inhibitor-Related Mortality in Non-Severe Hemophilia Α Patients in the United States

Ming Y. Lim, MBBChir,MA, Dunlei Cheng, PhD, Christine L. Kempton, MD MSc, Nigel S. Key, MBChB, FRCP

Blood (2019) 134 (Supplement_1): 902.

https://doi.org/10.1182/blood-2019-122991

Published: 2019

Journal Articles

Validation of Instrument to Assess Hemophilia-Related Distress

Christine L. Kempton, MD MSc, Vaughn Barry, PhD MPH, Tyler W. Buckner, MD MSc, Janet Figueroa, MPH, Shanna Mattis, MPH, Mary Ellen Lynch, PhD, Mary E Stout, MD, Stephanie Whitten, Scott Gillespie, Courtney McCracken, PhD

Blood (2019) 134 (Supplement_1): 936.

https://doi.org/10.1182/blood-2019-122544

Published: 2019

Journal Articles

Epidemiology of Inhibitors in Persons with Severe Hemophilia a in the United States: Analyses of a National Database

Christopher M Sande, BSc, Amanda B Payne, MPH, PhD, Christine L Kempton, MD MSc, Marilyn J Manco-Johnson, MD, Anjali Sharathkumar, MBBS, MDMS

Blood (2018) 132 (Supplement 1): 2470.

https://doi.org/10.1182/blood-2018-99-109978

Published: 2018

Journal Articles

Outcomes of Direct Oral Anticoagulant- and Warfarin-Associated Hemorrhage: A Single Center Retrospective Cohort Study

Lorraine Cafuir, MD, En Cheng, Christine L Kempton, MD MSc

Blood (2018) 132 (Supplement 1): 826.

https://doi.org/10.1182/blood-2018-99-110685

Published: 2018

Journal Articles

Linear and Logistic Regression Models of Patient-Reported Outcomes and Patient Characteristics in US Adults with Hemophilia from the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

Katharine Batt, MD MSc, Michael Recht, MD PhD, Michael Wang, MD, Doris V. Quon, MD PhD, Lisa N Boggio, MD MS, Craig M. Kessler, MD, Tyler W. Buckner, MD MSc, Anne T. Neff, MD, Neeraj N Iyer, PhD, David L Cooper, MD MBA, Christine L Kempton, MD MSc

Blood (2016) 128 (22): 252.

https://doi.org/10.1182/blood.V128.22.252.252

Published: 2016

Journal Articles

Numeracy in Patients with Hemophilia

Duc Q. Tran, MD MSc, Vaughn Barry, PhD MPH, Ana G. Antun, MD, Maria Ribeiro, MD, Sidney F. Stein, MD, Christine L Kempton, MD MSc

Blood (2015) 126 (23): 40.

https://doi.org/10.1182/blood.V126.23.40.40

Published: 2015

Journal Articles

Impact of Pain and Functional Impairment in US Adult People with Hemophilia (PWH): Patient-Reported Outcomes and Musculoskeletal Evaluation in the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

Christine L Kempton, MD MSc, Michael Recht, MD PhD, Anne Neff, MD, Michael Wang, MD, Tyler W. Buckner, MD MSc, Amit Soni, MD, Doris Quon, MD PhD, Michelle Witkop, DNP, FNP-BC, Lisa Boggio, MD, David L Cooper, MD MBA

Blood (2015) 126 (23): 39.

https://doi.org/10.1182/blood.V126.23.39.39

Published: 2015

Journal Articles

Non-Factor VIII Coagulation Proteins Fail to Predict Joint Outcome in Severe Hemophilia a

Beth Boulden Warren, MD MS, Linda Jacobsen, BS, Elizabeth Villalobos-Menuey, BS, Thomas C. Abshire, MD, Amy D Shapiro, MD, Michael Recht, MD PhD, Deborah Brown, MD, Cindy A. Leissinger, MD, Christine L. Kempton, MD MSc, Heidi Lane, PT, DPT, PCS, Diane J. Nugent, MD, Marilyn J. Manco-Johnson, MD

Blood (2015) 126 (23): 2289.

https://doi.org/10.1182/blood.V126.23.2289.2289

Published: 2015

Journal Articles

The Impact of Health Literacy on Adherence to Factor Replacement in the Hemophilia Population

Duc Q. Tran, MD, Vaughn Barry, PhD MPH, Ana G. Antun, MD, Maria J.A. Ribeiro, MD, Sidney F. Stein, MD, Christine L. Kempton, MD

Blood (2014) 124 (21): 2173.

https://doi.org/10.1182/blood.V124.21.2173.2173

Published: 2014

Journal Articles

Distress in Patients with Bleeding Disorders

Vaughn Barry, PhD MPH, Duc Q. Tran, MD, Mary Ellen Lynch, PhD, Hilary G Cohen, LCSW, CTS, DVC (III), Cedric Truss, MSHI, Kesley Tyson, MS, CCRP, Ana G. Antun, MD, Anthony DeBalsi, NP, Shanna Mattis, MPH, Maria J.A. Ribeiro, MD, Sidney F. Stein, MD, Christine L. Kempton, MD

Blood (2014) 124 (21): 201.

https://doi.org/10.1182/blood.V124.21.201.201

Published: 2014

Journal Articles

A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population

Blood (2014) 124 (21): 2836.

https://doi.org/10.1182/blood.V124.21.2836.2836

Published: 2014

Journal Articles

Postoperative Deep Vein Thrombosis (DVT) In Patients With Hemophilia Undergoing Major Orthopedic Surgery

Tyler W. Buckner, MD, Leavitt Andrew, MD, Margaret V. Ragni, M. Elaine Eyster, MD, Christine L. Kempton, MD, MSc, Nigel S Key, MBChB

Blood (2013) 122 (21): 207.

https://doi.org/10.1182/blood.V122.21.207.207

Published: 2013

Journal Articles

Natural History Of Inhibitor Recurrence Following Successful Immune Tolerance Induction

Ana G. Antun, MD, Paul Monahan, MD, Marilyn J. Manco-Johnson, MD, Michael Callaghan, MD, Guy Young, MD, Christine Knoll, MD, Shannon Carpenter, MD, MS, Joanna A. Davis, MD, Michael F. Guerrera, MD, Rebecca Kruse-Jarres, MD, MPH, Margaret V. Ragni, MD, MPH, Char Witmer, MD, MSCE, Courtney E. McCracken, PhD, Maralee Kanin, Christine L. Kempton, MD, MSc

Blood (2013) 122 (21): 1106.

https://doi.org/10.1182/blood.V122.21.1106.1106

Published: 2013

Journal Articles

Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis

Uri Martinowitz, MD, Amy D. Shapiro, MD, Doris V. Quon, MD, PhD, Miguel Antonio Escobar, MD, Christine L Kempton, MD, MSc, Peter Collins, MD, Pratima Chowdary, MD, Michael Makris, MD, Pier Mannuccio Mannucci, MD, Massimo Morfini, MD, Leonard A. Valentino, MD, Edward D. Gomperts, MD, Martin Lee, PhD

Blood (2011) 118 (21): 2267.

https://doi.org/10.1182/blood.V118.21.2267.2267

Published: 2011

Journal Articles

Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

Blood (2011) 118 (21): 2275.

https://doi.org/10.1182/blood.V118.21.2275.2275

Published: 2011

Journal Articles

Predictors of Von Willebrand Disease In Children: A Case-Control Study

Heather L. Bujnicki, B.S., Robert F. Sidonio, MD, MPH, Charity G. Moore, MSPH, PhD, Christine L. Kempton, MD, MSc, Peter A. Kouides, MD, Roshni Kulkarni, MD, Diane J. Nugent, MD, Donald L. Yee, MD, Margaret V. Ragni, MD, MPH

Blood (2010) 116 (21): 712.

https://doi.org/10.1182/blood.V116.21.712.712

Published: 2010

Journal Articles

Recombinant Human Von Willebrand Factor (rhVWF): First-In-Human Study Evaluating Pharmacokinetics, Demonstrating Safety and Tolerability In Type 3 Von Willebrand Disease

Tobias Suiter, MD, Michael Laffan, DM, FRCP, FRCPath, Pier M. Mannucci, MD, Christine L. Kempton, MD, MSc, Edward H Romond, MD, Amy D. Shapiro, MD, Ingvild Birschmann, MD, PhD, Joan Cox Gill, MD, Margaret V. Ragni, MD, MPH, Peter Turecek, PhD, Bruce M. Ewenstein, MD, PhD, VrWF Study Team Baxter BioScience

Blood (2010) 116 (21): 237.

https://doi.org/10.1182/blood.V116.21.237.237

Published: 2010

Journal Articles

N1922S Mutation In the Factor VIII A3 Domain Produces a Rate-Limiting, Domain-Specific Folding Defect Leading to Hyposecretion of a Functional Protein

Ryan J. Summers, B.S., Shannon L. Meeks, MD, John F. Healey, B.S., Harrison C. Brown, BBA, Ernest T Parker, BA, Christopher Doering, PhD, Christine L. Kempton, MD, MSc, John (Pete) S. Lollar, III, MD

Blood (2010) 116 (21): 2209.

https://doi.org/10.1182/blood.V116.21.2209.2209

Published: 2010

Journal Articles

Risk Factors for Inhibitor Development in Mild and Moderate Hemophilia A: A Case-Control Study.

Christine L Kempton, MD, MSc, J. Michael Soucie, Ph.D, Connie H. Miller, PhD, Craig Hooper, PhD, Miguel A. Escobar, MD, Mark T. Reding, MD, Alice J. Cohen, MD, Nigel S. Key, MBChB, Arthur R. Thompson, M.D., Ph.D., Marilyn J. Manco-Johnson, Thomas C. Abshire, MD

Blood (2009) 114 (22): 3184.

https://doi.org/10.1182/blood.V114.22.3184.3184

Published: 2009

NARROW

Bone and Joint Health Markers in Persons with Hemophilia A (PwHA) Treated with Emicizumab in HAVEN 3

All-Cause and Inhibitor-Related Mortality in Non-Severe Hemophilia Α Patients in the United States

Validation of Instrument to Assess Hemophilia-Related Distress

Epidemiology of Inhibitors in Persons with Severe Hemophilia a in the United States: Analyses of a National Database

Outcomes of Direct Oral Anticoagulant- and Warfarin-Associated Hemorrhage: A Single Center Retrospective Cohort Study

Linear and Logistic Regression Models of Patient-Reported Outcomes and Patient Characteristics in US Adults with Hemophilia from the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

Numeracy in Patients with Hemophilia

Impact of Pain and Functional Impairment in US Adult People with Hemophilia (PWH): Patient-Reported Outcomes and Musculoskeletal Evaluation in the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study

Non-Factor VIII Coagulation Proteins Fail to Predict Joint Outcome in Severe Hemophilia a

The Impact of Health Literacy on Adherence to Factor Replacement in the Hemophilia Population

Distress in Patients with Bleeding Disorders

A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population

Postoperative Deep Vein Thrombosis (DVT) In Patients With Hemophilia Undergoing Major Orthopedic Surgery

Natural History Of Inhibitor Recurrence Following Successful Immune Tolerance Induction

Pharmacokinetic Behavior of IB1001, An Investigational Recombinant Factor IX, in Patients with Hemophilia B: Repeat Pharmacokinetic Study and Subgroup Analysis

Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

Predictors of Von Willebrand Disease In Children: A Case-Control Study

Recombinant Human Von Willebrand Factor (rhVWF): First-In-Human Study Evaluating Pharmacokinetics, Demonstrating Safety and Tolerability In Type 3 Von Willebrand Disease

N1922S Mutation In the Factor VIII A3 Domain Produces a Rate-Limiting, Domain-Specific Folding Defect Leading to Hyposecretion of a Functional Protein

Risk Factors for Inhibitor Development in Mild and Moderate Hemophilia A: A Case-Control Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only